BioPharm News

Mar 03, 2015
By BioPharm International Editors
Canon announced that it established Canon BioMedical, a wholly owned biomedical business to develop, manufacture, and market operations related to Canon’s life-science and molecular diagnostics platform.
BioPharm International: Mar 03, 2015
By BioPharm International Editors
The upgrades will offer the opportunity for higher product yields and higher purity levels.
Feb 27, 2015
By BioPharm International Editors
FDA announced that it would postpone a meeting that would be critical for the advancement of Celltrion’s Remicade biosimilar in the US.
BioPharm International: Feb 25, 2015
Remsima will now be available for patients in 12 additional countries in the European Union.
BioPharm International: Feb 24, 2015
Drug shortages are declining, but they’re still a serious concern for regulatory authorities, policy makers, and bio/pharmaceutical manufacturers.
BioPharm International: Feb 24, 2015
By BioPharm International Editors
Baxter announced that its new biopharmaceutical arm, scheduled to become independent from Baxter in 2015, will be located in Bannockburn, Illinois.
BioPharm International: Feb 24, 2015
By BioPharm International Editors
The company voluntarily recalls product due to FDA observations of potential sterility problems.
BioPharm International: Feb 23, 2015
By BioPharm International Editors
The agency cites Apotex’s Bangalore facility with quality system failures.
Feb 23, 2015
By BioPharm International Editors
Leased facilities in California will expand Kite Pharma's capacity for T-cell therapies.
BioPharm International: Feb 20, 2015
By BioPharm International Editors
The Patent and Trademark Office sends notice rejection of the company’s Remicade patent.